The long-acting form of Hydrocodone was approved for medicinal use in the United States in 2013. As of 2010, the United States accounted for 99% of the global supply of Hydrocodone. In 2018, it was the 402nd most commonly prescribed drug in the US, with over 400,000 prescriptions